Screenshot 2024-06-24 at 07.44.05
Screenshot 2024-06-24 at 07.44.05
Screenshot 2024-06-24 at 07.44.05
Analyzer
LD-560
Experience in HbA1c
b
AH
2 Product Features
1 b 3 Competitors Analysis
c A
1
c
Overview
01 02 03
What is Diabetes? Status of Diabetes Authority of HbA1c
Diabetes is a chronic, metabolic According to WHO, about 537 ADA, EASD and IDF
disease characterized by million people worldwide have unanimously recommended
elevated levels of blood glucose diabetes, and 1.5 million deaths are HbA1c as an auxiliary screening
(or blood sugar), which leads directly attributed to diabetes each and diagnostic indicator for
over time to serious damage to year. diabetes in 2009, and finally
the heart, blood vessels, eyes, officially increased HbA1c as an
kidneys and nerves. indicator in the 2010 edition of
Recommendations for HbA1c testing the ADA diagnostic guidelines
as one of the diagnostic
Every Patient with diabetes is adviced to have their HbA1c tested indicators of diabetes.
for 2-4 times annually.
537 million
Diabetes
2021 2030 2045
8 billion
537 643 783
Diabetes Development Process
1 2 3 4
1
Glycated Hemoglobin is the product of irreversible enzymatic
reaction between sugars in blood and hemoglobin in erythrocyte
referred to as HbA1(including HbA1a, HbA1b, HbA1c )
2
HbA1c’s content mainly depends on the blood glucose
concentration and the contact time between blood glucose and
hemoglobin, which can reflect the average blood glucose level in
the 120 days before the measurement.
Enzymatic reactions 3
The ratio of HbA1c to total hemoglobin (%) is used clinically to
represent the concentration of HbA1c, and the HbA1c level of
normal people is 4-6%.
The Element of
Hemoglobin
Hb
• HbA0 • HbA1
• Non-glycated Hb • Glycated Hb
• 94% • 6%
Product of the combination between HbA and Form from the combination betwee HbA and
fructose / lactose glucose, and is 60-70% of total HbA1
Clinical Detection
Application Significance
As an indicator of diabetes screening and
diagnosis.
Health Check-up
Screening
Evaluating the overall control of blood sugar
Finding problems in the treatment
Blood Sugar
Guiding the adjustment of the treatment plan
Monitoring for diabetics.
Primary Medical
Institutions
Women’s and Children's
Hospitals
Diabetes Specialist
Hospitals
Elderly Care
Institutions
Laborator
y
Product Features
The Fully Automated HbA1c Analyzer is used in conjunction with
suitable reagents for the quantitative detection of glycosylated
hemoglobin (HbA1c) in human blood.
5 User Friendly
HPLC Principle
40
40
30
30
20
20
10
10
0
0 10 20 30 40
0
0 10 20 30
Correlation between LD-560 and Tosoh G8 & Bio-Rad D10
Full Automatic Smart System
Quality Assurance
IFCC & NGSP ISO Certificated
Certificated
User Friendly
Auto washing
Carousel injection
Auto washing for self maintenance at startup
Reagent level alarm
Variant Mode
• Detection for HbA2 & HbF
• Fully compatible with Bio-Rad’s
calibrators (HbA2 & HbF)
Fast Mode:
• Test speed: 90s/T
• Original HbA1c control and
Calibrator
Reagent Comsumables
Warranty
Device: 1 Year
Sampling Probe: 6 Months
Specifications
Methodology High Performance Precision CV≤2%
Liquid Chromatography
(HPLC)
Test Mode Fast Mode, Variant Mode Report Range 3%-18%
Test Speed 90s/Test Parameter HbA1c, HbF, HbA1a, HbA1b,
HbA0, HbA2(Optional)
Autoloader 20 Samples Sample Type Whole Blood, Pre-Diluted Blood
Capacity
Column Capacity 3000T Filter 600T
Storage 5000 Sample Result Reagent Kit Eluent A, Eluent B, Eluent
C(Variant Mode), Hemolysin,
Control, Calibrator
Weight 28 Kgs Dimension 378(L)*380(W)*510mm(H)
Competitors Analysis
v
s Bio-Rad D10 Labnovation LD-560
Model
Model
Variant Mode √ √
Variant Mode √ √
v
s
Arkray HA-8380V Labnovation LD-560
Model
Variant Mode √ √
Variant Mode √ √
Screen 10.1” TFT LCD Touch Screen 10” LCD touh screen
v Lifotronic
s Lifotronic H9 Labnovation LD-560
Model 102万
Model 49.2
Variant Mode √ √
Appreciate for
Your listening